Health Insurance Review Service Announces Results of Pharmaceutical Reimbursement Evaluation Committee’s Second Discussion

The post Health Insurance Review Service Announces Results of Pharmaceutical Reimbursement Evaluation Committee’s Second Discussion appeared first on News Directory 3.
On the 1st, the Health Insurance Review and Assessment Service released the results of the second discussion of the Pharmaceutical Reimbursement Evaluation Committee. [메디칼업저버 이주민 기자] Enhertu (trastuzumab deruxtecan) and Ilaris injection (canakinumab, genetically recombinant) passed the Pharmaceutical Reimbursement Evaluation Committee review and were recognized as appropriate for reimbursement. However, Ilaris injection was only approved […]